Waste Management Inc. Overview
WM is North America's largest integrated environmental-services company. It controls the continent's largest landfill network and collection fleet. It is the largest post-consumer recycler and a leading producer of renewable natural gas (RNG) from landfill gas. It runs the industry's largest heavy-duty natural-gas truck fleet, at more than 12,000 trucks [S1].
The core franchise is a vertically integrated collection-transfer-disposal network with high internalization, at 73.0% of disposal costs in Q2 FY2026 [S2]. That network generated a 38.6% adjusted segment EBITDA margin in Q2 FY2026 and supports durable pricing power, with core price of 5.7% in Q2 FY2026 [S2].
Since 2024, WM has added a regulated medical-waste and secure-shredding platform through the $7.2B Stericycle acquisition [S9]. It has also nearly completed a roughly $3B multi-year build-out of recycling automation and RNG plants. Management expects those projects to lift combined sustainability EBITDA toward $1B in 2027 [S1].
The 2026 equity story is "harvest mode." Capex is falling, free cash flow is guided up about 29% to $3.75–3.85B, and about $3.5B is planned for shareholder returns [S1]. Leadership passes from Jim Fish to John Morris in January 2027 [S6].
Company self-description (paraphrased from the FY2025 proxy and 10-K language) [S4]. Waste Management, Inc. describes itself as a holding company whose operations are all conducted through subsidiaries. Those subsidiaries are managed locally within distinct geographic markets.
-
WM positions itself as North America's leading provider of comprehensive environmental solutions across the U.S. and Canada.
-
It partners with customers and communities to manage and reduce waste at each stage from collection to disposal.
-
It recovers materials and produces renewable energy along the way.
-
Since the 2024 Stericycle acquisition, its Healthcare Solutions segment provides regulated waste, compliance and secure information destruction services in the U.S., Canada and Western Europe.
Independent characterization. WM is best understood as an infrastructure-like, route-density business layered on top of a scarce-asset disposal monopoly.
Collection: Collection generates about 61% of net revenue (FY2025: $15.42B of $25.20B) [S1]. Pricing is driven by contracts and subscriptions.
Disposal: Landfills and transfer stations generate about 21% of net revenue (FY2025: $5.28B) [S1].
Strategic moat: The landfill and transfer network is the real moat. New landfill permits are scarce and slow, so owners of permitted airspace capture tipping-fee economics and internalize their own collected volumes. This drives superior margins versus collection-only competitors.
Recycling and Renewable Energy: These are commodity-exposed businesses that are being "de-risked." Automation lowers processing cost per ton, and fees and offtake contracts reduce price exposure. Even so, single-stream commodity prices ($65–75/ton in H1 FY2026) and RIN prices ($2.32–2.33) remain swing factors [S2][S3].
Healthcare Solutions: The former Stericycle business is a route-based specialty-services adjacency. It covers regulated medical waste, pharmaceutical and hazardous waste, and Shred-it-type secure information destruction (SID). It is margin-dilutive today, at a 16.9% adjusted EBITDA margin in FY2025 [S1], but is being integrated into WM's field structure.
Revenue model mix (FY2025 net operating revenue) [S1]
Characterization of the mix:
Service and subscription: About 92% of revenue comes from contracted, recurring or tonnage-based services.
Product-like: About 8% is commodity or energy revenue from recycled materials, RNG and RINs.
Licensing: Licensing revenue is immaterial or nil.
Value-chain position. WM spans the whole post-consumer value chain:
-
Generation-point services: containers, compactors and Bagster.
-
Collection logistics.
-
Transfer and consolidation.
-
Processing: material recovery facilities (MRFs), organics and medical-waste treatment through autoclave and incineration.
-
Final disposal: landfill.
-
Energy and material monetization: landfill-gas-to-electricity, RNG and sale of recycled commodities.
Customer types and end-markets.
Customers: Residential households (subscription and municipal contract), commercial businesses, industrial and construction sites, municipalities, national accounts, healthcare providers (hospitals, clinics, physician and dental offices, pharmacies) and document-sensitive enterprises for SID [S1][S4].
End-markets: Housing and construction activity drives roll-off volumes. Retail, hospitality and office activity drive commercial volumes. Industrial production drives special waste. Healthcare utilization drives regulated medical waste. Packaging and paper markets drive recycled-commodity demand. Transportation fuel markets drive RNG demand under the Renewable Fuel Standard and low-carbon fuel standards.
Strategy
Stated corporate strategy (themes, paraphrased from the 2026 proxy and FY2025 earnings materials) [S1][S4].
-
"Focused differentiation and continuous improvement." This is the long-standing core strategy and is described as unchanged [S4].
-
"People-first, technology-led." Reduce frontline turnover, automate collection and processing, and digitize customer interactions [S4].
-
Disciplined pricing to maximize customer lifetime value. Price above cost inflation and shed unprofitable business, especially residential [S1].
-
Sustainability as growth. Invest in recycling automation and RNG to create higher-return, lower-carbon earnings streams [S1].
-
Comprehensive environmental solutions. Broaden the portfolio through Healthcare Solutions and cross-selling [S1].
-
Capital allocation. Harvest investments, keep leverage at 2.5–3.0x, pursue tuck-in M&A of $100–200M per year, and return most free cash flow [S1].
Strategic initiatives announced or advanced in the last 24 months (Oct 2024 – Oct 2026)
Management guidance (FY2026, as updated Jul 28, 2026) [S2]
Products & Services
Pricing models are disclosed only qualitatively. Launch years are given where known. WM does not publish list prices for most commercial services.
Collection and Disposal
| Offering | Description / capabilities | Target customer | Pricing model | Notes |
|---|---|---|---|---|
| Residential Trash Collection & Recycling | Curbside cart-based trash and single-stream recycling, increasingly by automated side-load trucks | Households, HOAs, municipalities | Monthly subscription or municipal franchise rate, often CPI-linked | WM is deliberately shedding low-margin residential contracts; residential volume was -3.9% in H1 FY2026 against +6.2% yield [S2] |
| Commercial Waste Disposal & Recycling | Front-load dumpsters, compactors and scheduled service | Retail, office, restaurants, multifamily | Contracted monthly rate plus fees (energy surcharge, environmental fee) | Largest collection line: FY2025 net revenue $5.63B [S1] |
| Roll-Off Dumpster Rental (10-, 20-, 30-, 40-yard) | Temporary and permanent open-top containers | Contractors, demolition, home projects | Per-haul plus disposal per ton, rental days | Industrial line: FY2025 $3.11B [S1] |
| Construction Waste Disposal | Construction and demolition debris handling and diversion | General contractors | Per-haul or tonnage | Cyclical exposure to construction |
| Bagster® (Dumpster in a Bag®) | Retail-purchased bag with WM pickup | DIY homeowners | Bag purchase plus pickup fee | Consumer channel |
| Bulk Trash Pickup | On-demand large-item pickup | Households | Per-item or per-pickup | Digital booking |
| eWaste, bulbs and batteries | Mail-back and drop-off for universal waste | Households, small business | Kit or box price | Specialty recycling |
| National Accounts | Single-vendor outsourced waste program management for multi-site customers, including Oakleaf-heritage brokerage | Retail chains, multi-site corporations | Managed-services contracts | Uses third-party haulers where WM has no presence |
| Landfill disposal (MSW, special waste) | About 260 active solid waste landfills plus 5 secure hazardous landfills (approximate; 10-K counts not re-verified) | Third-party haulers, municipalities, industry | Tipping fee per ton or yard; special-waste premium | MSW yield +5.9% in H1 FY2026 [S2]; internalization 72.4% in H1 FY2026 [S2] |
| Transfer stations | Consolidation of collected waste for long-haul to landfill | Haulers, municipalities | Per-ton fee | FY2025 net transfer revenue $1.50B [S1] |
| Energy & Environmental Services / Industrial | Industrial cleaning, oil recovery and sludge processing, remediation | Industrial clients | Project and contract | A $16M goodwill impairment in 2025 related to an oil recovery and sludge processing business [S1] |
| Fly ash management | Marketing and beneficial use of coal-combustion residuals | Utilities | Contract | Small |
Recycling Processing and Sales
| Offering | Description | Target customer | Pricing model | Recent developments |
|---|---|---|---|---|
| Single-stream MRF processing | Automated optical and robotic sorting of mixed recyclables | Municipal programs, WM's own collection | Processing fees plus commodity revenue share or rebate | 2026 openings: Ontario (Canada) and Detroit MRFs, plus a South Florida automation project now WM's largest single-stream facility (about 300,000 tons combined) [S3]. Denver MRF added about 60,000 tons/year [S2]. |
| Commodity sales and brokerage (WM Recycle America heritage) | Sale of OCC, mixed paper, PET, HDPE, aluminum, steel, glass | Mills, converters | Market price; rebates booked as cost of goods sold ($712M in FY2025) [S1] | Blended single-stream price about $75/ton in Q2 FY2026 versus $84/ton in Q2 FY2025 [S2] |
| Organics | Composting, food-waste depackaging and slurry, yard waste | Municipalities, grocers, food service | Tipping or processing fees | Supports diversion goals |
| Plastic film and wrap recycling | Venture to accelerate film recycling | Retail and logistics generators | — | Operations temporarily suspended in 2025; $162M impairment [S1] |
| Advisory / Sustainability Services | Waste audits, diversion strategy and reporting | Large corporates | Fee-based | Now under COO Tara Hemmer [S7] |
Renewable Energy
| Offering | Description | Customer | Pricing model | Metrics |
|---|---|---|---|---|
| Renewable Natural Gas (RNG) | Landfill gas upgraded to pipeline-quality RNG, used as transportation fuel | Fuel marketers, utilities, WM fleet | About 60% of 2026 volume contracted at about $27/MMBtu blended; remainder at market of about $24.50; overall about $26/MMBtu [S1] | 2026 production guidance 21–22 million MMBtu [S1]; 3 plants completed in Q2 FY2026 (2 in South Carolina, 1 in Florida), adding about 3.5 million MMBtu run-rate [S2] |
| Environmental attributes (RINs, LCFS) | D3 RIN generation under the Renewable Fuel Standard | Obligated parties | Market | RIN about $2.33 in Q2 FY2026 [S2]; sensitivity about $6M EBITDA per $0.10 on the uncontracted portion [S1] |
| Landfill-gas-to-electricity | Most LFG-to-electricity plants in North America [S1] | Utilities and grid | PPA or merchant (about $69/MWh in Q2 FY2026) [S2] | Legacy base of LFG projects |
Healthcare Solutions (former Stericycle)
| Offering | Description | Target customer | Pricing model | Notes |
|---|---|---|---|---|
| Regulated Medical Waste (RMW) | Collection, transport and treatment by autoclave and incineration | Hospitals, clinics, physician and dental offices, labs | Contracted service (container/route), often multi-year | At closing Stericycle had 18 incinerators, 69 autoclave/alternative treatment facilities and 167 transfer stations [S21] |
| Pharmaceutical and hazardous waste | Compliant disposal of pharmaceutical waste and hazardous materials | Pharmacies, hospitals | Per-container or contract | Specialized permits |
| Sharps disposal / mail-back | Sharps containers and mail-back | Clinics, retail health | Kit or contract | — |
| Compliance programs (Steri-Safe heritage) | OSHA/HIPAA training and compliance tools | Small healthcare practices | Subscription | Cross-sell target |
| Secure Information Destruction (Shred-it heritage) | Scheduled and one-time on-site or off-site shredding; paper recycled through WM | Enterprises, legal, finance, healthcare | Subscription and per-purge | Western Europe exposure (Spain and Portugal sold Jan 2025) [S9] |
Integration status. Healthcare Solutions was integrated into WM's field management and operating structure in Q4 FY2025 [S1]. Management targets about $300M of run-rate synergies, including cross-selling, by 2027 [S18]. 2026 HCS revenue growth is guided at about 3%, primarily from price [S1]. In practice, H1 FY2026 HCS revenue was down 1.0% [S2].
Financial Narrative
Basis. FY2021–FY2024 come from audited 10-K XBRL statements [S5]. FY2025 comes from the Jan 28, 2026 release [S1], which is consistent with the FY2025 10-K filed Feb 9, 2026.
The definitions used here are:
"Gross profit": is computed as revenue less operating expenses (excluding DD&A). It is not a WM-reported line.
"Operating EBITDA": follows WM's pre-2026 definition: GAAP income from operations plus DD&A.
Income statement
Notes:
-
FY2021 includes a $220M loss on early extinguishment of debt [S5].
-
FY2023 includes $243M of divestiture, impairment and unusual items, among them a $168M goodwill impairment [S5].
-
FY2025 includes $248M of such items, mainly the $162M plastic film impairment and a $45M accelerated East Tier landfill closure impairment. It also includes $137M of Stericycle integration costs [S1].
-
FY2023 adjusted EPS of $6.19 is per the FY2023 earnings release.
Margins and growth (%)
Revenue CAGR FY2021–FY2025: 8.9% (computed).
Organic versus acquired, FY2025: internal revenue growth was 3.7% and acquisitions contributed 10.7% of the 14.2% growth [S1].
FY2021 base effect: FY2021 growth was flattered by the Advanced Disposal consolidation and the COVID rebound.
Balance sheet
Latest balance sheet (Jun 30, 2026) [S2].
-
Total assets: $46,441M.
-
Cash: $557M.
-
Debt: current $1,075M plus long-term $22,281M, for total debt of $23,356M and net debt of $22,799M.
-
Equity: WM stockholders' equity of $9,925M.
-
Leverage: covenant-defined leverage was 2.96x, inside the 2.5–3.0x target range [S23][S3].
Cash flow
Notes:
-
FY2022–FY2025 figures are from [S5] and [S1].
-
Buybacks were suspended from Q3 FY2024 through FY2025 to delever after the Stericycle deal. They resumed in Q1 FY2026, with $1,003M repurchased in H1 FY2026 [S2].
Ratios (computed from the tables above)
Cash conversion cycle: Not meaningful for an asset-heavy service business with negligible inventory (parts and supplies were only $173M in FY2023), and not disclosed. DSO is shown as the relevant working-capital metric.
FY2024 distortions: FY2024 leverage, turnover and DSO are inflated because the year-end balance sheet consolidates Stericycle while the income statement includes only about two months of it.
Leverage definition: WM's covenant leverage ratio uses a different definition from the net debt to EBITDA figures above.
Quarterly trend [S1][S2][S3]
Q3 FY2025 values are derived as the FY2025 total less Q1, Q2 and Q4.
Commentary on trends, inflections and drivers
Revenue. Revenue rose from $17.9B in FY2021 to $25.2B in FY2025, an 8.9% CAGR. Three phases are visible:
-
FY2021–FY2022. An inflation-driven price surge plus the Advanced Disposal consolidation.
-
FY2023. Volume normalization and lower recycled-commodity prices, giving only 3.7% growth.
-
FY2024–FY2025. The Stericycle step-up, with $2.37B of acquired revenue in FY2025 [S1].
Underlying C&D yield has been remarkably consistent at about 4%. C&D yield was 3.8% in FY2025 [S1] and 3.6% in Q2 FY2026 [S2]. Volume has turned negative in 2026, at -1.6% for C&D in H1 [S2], as wildfire cleanup rolls off and residential contracts are shed.
Margins. Computed gross margin expanded 240bp from FY2021 to FY2025, from 38.0% to 40.4%. This reflects a structural improvement in price-to-cost spread: Legacy Business operating expenses improved 150bp as a share of revenue in FY2025 [S1].
GAAP operating margin dipped in FY2025 to 17.1% from 18.4% for three reasons:
-
Stericycle's higher-SG&A, lower-margin mix.
-
Integration costs of $137M.
-
$248M of impairments [S1].
On an adjusted basis, total company margin crossed 30% for the first time in FY2025, at 30.1% [S1]. The new 2026 guidance range is 31.0–31.2% on the restated basis [S2].
Earnings. Diluted EPS rose from $4.29 to $6.81 between FY2021 and FY2024. It then dipped to $6.70 in FY2025 as interest expense rose $314M year over year on acquisition debt, from $598M to $912M [S1]. Adjusted EPS still grew 3.7% in FY2025 to $7.50.
H1 FY2026 diluted EPS of $3.74 is up 11% year over year [S2]. Interest expense has stabilized at about $230M per quarter [S2].
Balance sheet. Total debt rose by $7.7B in FY2024 to fund Stericycle. WM chose to delever rather than buy back stock through FY2025. Leverage returned to the 2.5–3.0x covenant target range in Q1 FY2026 [S3].
Goodwill plus intangibles now account for about 38% of total assets ($17.6B of $45.8B at FY2025 year-end), up from about 34% in FY2021. That raises impairment sensitivity, particularly at HCS.
Negative working capital is structural. Deferred revenues come from advance billing, and accrued liabilities exceed receivables.
Cash flow. OCF grew at about 8.7% CAGR from FY2021 to FY2025. The key 2026 inflection is the capex roll-off:
-
Sustainability growth capex falls from $633M in FY2025 to about $200–250M in 2026 [S1][S2].
-
Support capex falls by about $100M [S1].
-
Together these lift free cash flow toward $3.75–3.85B, roughly 29% growth.
H1 FY2026 free cash flow was $2.02B, up 56.5% [S2]. 100% bonus depreciation, restored by 2025 U.S. tax legislation, also supports cash taxes [S18].
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment (USD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Collection and Disposal revenue (USD Mn) | — | 19,716 | 20,704 |
Recycling Processing and Sales revenue (USD Mn) | — | 1,603 | 1,492 |
Renewable Energy revenue (USD Mn) | — | 318 | 478 |
Healthcare Solutions revenue (USD Mn) | 0 | 403 | 2,508 |
Corporate and Other revenue (USD Mn) | — | 23 | 22 |
Total revenue (USD Mn) | 20,426 | 22,063 | 25,204 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (Half-Yearly)
| Segment (USD Mn) | H1 FY2025 | H1 FY2026 | YoY % |
|---|---|---|---|
Collection and Disposal | 10,203 | 10,560 | 3.5 |
Recycling Processing and Sales | 765 | 771 | 0.8 |
Renewable Energy | 206 | 316 | 53.4 |
Healthcare Solutions | 1,265 | 1,252 | -1.0 |
Corporate and Other | 9 | 12 | 33.3 |
Total | 12,448 | 12,911 | 3.7 |
Segment Revenue
| Segment | FY2024 % of revenue | FY2025 % of revenue | FY2025 YoY growth % |
|---|---|---|---|
Collection and Disposal | 89.4 | 82.1 | 5.0 |
Recycling Processing and Sales | 7.3 | 5.9 | -6.9 |
Renewable Energy | 1.4 | 1.9 | 50.3 |
Healthcare Solutions | 1.8 | 10.0 | n.m. (FY2024 includes about 2 months) |
Corporate and Other | 0.1 | 0.1 | -4.3 |
Results by Segment
| Segment (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Collection and Disposal income from operations (USD Mn) | 5,444 | 5,777 |
Recycling Processing and Sales income from operations (USD Mn) | 86 | -80 |
Renewable Energy income from operations (USD Mn) | 99 | 135 |
Corporate and Other income from operations (USD Mn) | -1,497 | -1,436 |
Healthcare Solutions income from operations (USD Mn) | -69 | -88 |
Total income from operations (USD Mn) | 4,063 | 4,308 |
Results by Segment by Segment Metric
| Segment metric (USD Mn) | FY2024 | FY2025 |
|---|---|---|
C&D operating EBITDA reported (USD Mn) | 7,344 | 7,815 |
C&D operating EBITDA adjusted (USD Mn) | 7,333 | 7,889 |
RPS operating EBITDA reported (USD Mn) | 218 | 96 |
RPS operating EBITDA adjusted (USD Mn) | 221 | 271 |
RE operating EBITDA reported (USD Mn) | 135 | 202 |
RE operating EBITDA adjusted (USD Mn) | 142 | 214 |
HCS operating EBITDA reported (USD Mn) | 4 | 338 |
HCS operating EBITDA adjusted (USD Mn) | 61 | 424 |
Corporate and Other operating EBITDA adjusted (USD Mn) | -1,194 | -1,216 |
Total operating EBITDA adjusted (USD Mn) | 6,563 | 7,582 |
Segment margin (%)
| Segment margin (%) | FY2024 | FY2025 |
|---|---|---|
C&D reported margin (%) | 37.2 | 37.7 |
C&D adjusted margin (%) | 37.2 | 38.1 |
RPS reported margin (%) | 13.6 | 6.4 |
RPS adjusted margin (%) | 13.8 | 18.2 |
RE reported margin (%) | 42.5 | 42.3 |
RE adjusted margin (%) | 44.7 | 44.8 |
HCS reported margin (%) | 1.0 | 13.5 |
HCS adjusted margin (%) | 15.1 | 16.9 |
Total company adjusted margin (%) | 29.7 | 30.1 |
Revenue by Segment (H1 FY2025 (restated)–H1 FY2026)
| Segment (USD Mn) | H1 FY2025 (restated) | H1 FY2026 | YoY % |
|---|---|---|---|
Collection and Disposal | 3,875 | 4,072 | 5.1 |
Recycling Processing and Sales | 131 | 164 | 25.2 |
Renewable Energy | 87 | 143 | 64.4 |
Healthcare Solutions | 205 | 227 | 10.7 |
Corporate and Other | -589 | -686 | — |
Total | 3,709 | 3,920 | 5.7 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (USD Mn) | 17,931 | 19,698 | 20,426 | 22,063 | 25,204 |
Operating expenses (USD Mn) | 11,111 | 12,294 | 12,606 | 13,383 | 15,012 |
SG&A (USD Mn) | 1,864 | 1,938 | 1,926 | 2,264 | 2,722 |
DD&A (USD Mn) | 1,999 | 2,038 | 2,071 | 2,267 | 2,863 |
Gross profit, computed (USD Mn) | 6,820 | 7,404 | 7,820 | 8,680 | 10,192 |
Income from operations (USD Mn) | 2,965 | 3,365 | 3,575 | 4,063 | 4,308 |
Operating EBITDA, computed (USD Mn) | 4,964 | 5,403 | 5,646 | 6,330 | 7,171 |
Adjusted operating EBITDA, company (USD Mn) | — | — | — | 6,563 | 7,582 |
Interest expense, net (USD Mn) | 365 | 378 | 500 | 598 | 912 |
Pre-tax income (USD Mn) | 2,349 | 2,918 | 3,021 | 3,458 | 3,426 |
Income tax expense (USD Mn) | 532 | 678 | 745 | 713 | 717 |
Net income attributable to WM (USD Mn) | 1,816 | 2,238 | 2,304 | 2,746 | 2,708 |
EPS basic (USD) | 4.32 | 5.42 | 5.69 | 6.84 | 6.72 |
EPS diluted (USD) | 4.29 | 5.39 | 5.66 | 6.81 | 6.70 |
Adjusted EPS diluted (USD) | — | — | 6.19 | 7.23 | 7.50 |
Dividends declared per share (USD) | 2.30 | 2.60 | 2.80 | 3.00 | 3.30 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin, computed (%) | 38.0 | 37.6 | 38.3 | 39.3 | 40.4 |
Operating margin (%) | 16.5 | 17.1 | 17.5 | 18.4 | 17.1 |
Operating EBITDA margin, computed (%) | 27.7 | 27.4 | 27.6 | 28.7 | 28.5 |
Adjusted operating EBITDA margin, company (%) | — | — | — | 29.7 | 30.1 |
Net margin (%) | 10.1 | 11.4 | 11.3 | 12.4 | 10.7 |
Effective tax rate (%) | 22.6 | 23.2 | 24.7 | 20.6 | 20.9 |
Revenue growth YoY (%) | 17.8 | 9.9 | 3.7 | 8.0 | 14.2 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (USD Mn) | 29,097 | 31,367 | 32,823 | 44,567 | 45,835 |
Cash and equivalents (USD Mn) | 118 | 351 | 458 | 414 | 201 |
Current portion of debt (USD Mn) | 708 | 414 | 334 | 1,359 | 711 |
Long-term debt (USD Mn) | 12,697 | 14,570 | 15,895 | 22,541 | 22,196 |
Total debt (USD Mn) | 13,405 | 14,984 | 16,229 | 23,900 | 22,907 |
Net debt (USD Mn) | 13,287 | 14,633 | 15,771 | 23,486 | 22,706 |
WM stockholders' equity (USD Mn) | 7,124 | 6,849 | 6,903 | 8,252 | 9,990 |
Goodwill (USD Mn) | 9,028 | 9,323 | 9,254 | 13,438 | 13,880 |
Other intangibles (USD Mn) | 898 | 827 | 759 | 4,188 | 3,767 |
Goodwill plus intangibles (USD Mn) | 9,926 | 10,150 | 10,013 | 17,626 | 17,647 |
Current assets (USD Mn) | 3,069 | 3,551 | 3,804 | 4,774 | 4,910 |
Current liabilities (USD Mn) | 4,082 | 4,394 | 4,226 | 6,258 | 5,524 |
Working capital (USD Mn) | -1,013 | -843 | -422 | -1,484 | -614 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (USD Mn) | 4,338 | 4,536 | 4,719 | 5,390 | 6,043 |
Capital expenditures (USD Mn) | 1,904 | 2,587 | 2,895 | 3,231 | 3,227 |
Free cash flow, OCF less capex (USD Mn) | 2,434 | 1,949 | 1,824 | 2,159 | 2,816 |
Free cash flow, company definition incl. divestiture proceeds (USD Mn) | — | 1,976 | 1,902 | 2,317 | 2,937 |
Sustainability growth capex (USD Mn) | — | — | — | 950 | 633 |
Acquisitions, net of cash (USD Mn) | — | 377 | 170 | 7,488 | 395 |
Dividends paid (USD Mn) | 970 | 1,077 | 1,136 | 1,210 | 1,334 |
Share repurchases (USD Mn) | 1,350 | 1,500 | 1,302 | 262 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, NI / ending WM equity (%) | 25.5 | 32.7 | 33.4 | 33.3 | 27.1 |
ROA, NI / ending total assets (%) | 6.2 | 7.1 | 7.0 | 6.2 | 5.9 |
ROIC, NOPAT / (total debt + total equity) (%) | 11.2 | 11.8 | 11.6 | 10.0 | 10.4 |
Current ratio (x) | 0.75 | 0.81 | 0.90 | 0.76 | 0.89 |
Debt to equity (x) | 1.88 | 2.19 | 2.35 | 2.90 | 2.29 |
Net debt to operating EBITDA (x) | 2.68 | 2.71 | 2.79 | 3.71 | 3.17 |
Interest coverage, EBIT / net interest (x) | 8.1 | 8.9 | 7.2 | 6.8 | 4.7 |
Asset turnover, revenue / ending assets (x) | 0.62 | 0.63 | 0.62 | 0.50 | 0.55 |
Days sales outstanding, total receivables (days) | 51.8 | 51.0 | 51.3 | 61.0 | 58.7 |
Income Statement and Per-Share Data (Quarterly)
| Metric | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 |
|---|---|---|---|---|---|---|
Revenue (USD Mn) | 6,018 | 6,430 | 6,443 | 6,313 | 6,227 | 6,684 |
Net income (USD Mn) | 637 | 726 | 603 | 742 | 723 | 785 |
Diluted EPS GAAP (USD) | 1.58 | 1.80 | 1.49 | 1.83 | 1.79 | 1.95 |
Adjusted diluted EPS (USD) | 1.67 | 1.92 | 1.98 | 1.93 | 1.81 | 2.02 |
Revenue by Region
| Region (USD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Western Europe revenue, HCS (USD Mn) | 0 | — | — |
Total revenue (USD Mn) | 20,426 | 22,063 | 25,204 |
Revenue by Region (FY2024–H1 FY2026)
| Line of business (USD Mn) | FY2024 | FY2025 | H1 FY2025 | H1 FY2026 |
|---|---|---|---|---|
Commercial collection (USD Mn) | 5,371 | 5,630 | 2,778 | 2,914 |
Industrial collection (USD Mn) | 3,089 | 3,106 | 1,531 | 1,578 |
Residential collection (USD Mn) | 3,466 | 3,510 | 1,744 | 1,799 |
Other collection (USD Mn) | 2,964 | 3,175 | 1,549 | 1,643 |
Landfill (USD Mn) | 3,445 | 3,781 | 1,876 | 1,868 |
Transfer (USD Mn) | 1,381 | 1,502 | 725 | 758 |
Recycling Processing and Sales (USD Mn) | 1,603 | 1,492 | 765 | 771 |
Renewable Energy (USD Mn) | 318 | 478 | 206 | 316 |
Healthcare Solutions (USD Mn) | 403 | 2,508 | 1,265 | 1,252 |
Business Lines
| Line | FY2025 yield | FY2025 volume | H1 FY2026 yield | H1 FY2026 volume |
|---|---|---|---|---|
Commercial | 5.1 | -0.2 | 4.4 | -1.4 |
Industrial | 2.8 | -0.3 | 3.3 | 0.2 |
Residential | 5.4 | -4.7 | 6.2 | -3.9 |
MSW (landfill) | 6.5 | 2.9 | 5.9 | 1.3 |
Transfer | 4.9 | -2.1 | 3.4 | -1.9 |
Total C&D | 3.8 | 0.3 | 3.7 | -1.6 |
Valuation Snapshot
| Metric | Value | Note |
|---|---|---|
Price, Oct 7, 2026 close | $203.92 | — |
Approximate year-end 2025 price | ~$219.7 | Implied from 13F year-end valuations (Gates Trust: $6,357M / 28.93M shares) [S12] |
YTD price return (%) | -7.2 | Yahoo chart [S11] |
1-year price return (%) | -7.7 | Yahoo chart [S11] |
5-year price return (%) | 36.5 | Yahoo chart [S11] |
52-week range | $194.11 – $248.13 | — |
Beta (5Y monthly) | 0.43 | Defensive |
Mean 12-month price target | $259.92 (low $220, high $277); about 27% upside | [S11] |
Rating distribution (Barchart, spring 2026) | 28 analysts: 18 Strong Buy, 1 Moderate Buy, 9 Hold; consensus "Moderate Buy" | [S22] |
Recent actions | UBS $265 to $270, Buy (Aug 4, 2026); TD Cowen $270 to $275, Buy (Apr 29, 2026) | [S11][S22] |
Morningstar | Fair value estimate raised to $220 (date not specified) | [S11] |
Share Price
| Metric | FY2024 | FY2025 |
|---|---|---|
Year-end share price, approximate (USD) | 201.8 | 219.7 |
Valuation Multiples
| Multiple | WM | Basis |
|---|---|---|
P/E, trailing GAAP | 28.9x | EPS TTM $7.06 [S11] |
P/E, trailing adjusted | 26.3x | Adjusted EPS TTM $7.74 = FY2025 $7.50 + H1 FY2026 $3.83 − H1 FY2025 $3.59 [S1][S2][S3] |
EV/EBITDA, trailing adjusted | 13.1x | EV $104.3B / TTM adjusted EBITDA about $7.94B (new accretion-excluded basis) |
EV/EBITDA, 2026E guidance midpoint | 12.7x | $8.2B |
EV/Sales, trailing | 4.1x | TTM revenue $25.67B [S11] |
P/B | 8.2x | Equity $9.93B (Jun 30, 2026) [S2] |
Dividend yield | 1.85% | $3.78 annualized [S20] |
FCF yield, 2026E | ~4.7% | $3.8B midpoint / $81.5B market cap |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Annual dividend per share (USD) | 2.30 | 2.60 | 2.80 | 3.00 | 3.30 |
Dividends paid (USD Mn) | 970 | 1,077 | 1,136 | 1,210 | 1,334 |
Payout ratio, GAAP (%) | 53.4 | 48.2 | 49.5 | 44.1 | 49.3 |
Authorization Details
| Authorization | Date | Size | Status |
|---|---|---|---|
Prior program | 2023 | $1.5B | Superseded Dec 2025 |
Current program | Dec 2025 | $3.0B | $344M used in Q1 FY2026 and $659M in Q2 FY2026, about $1.0B in H1; about $2B planned for 2026 [S2][S3][S20] |
Credit Ratings
| Agency | Rating | Date / source |
|---|---|---|
S&P Global | A- | Assigned to Oct 2024 notes [S10] |
Fitch | A- | Assigned to Oct 2024 notes (upgraded from BBB+ by Jun 2024) [S10] |
Moody's | A3 | Assigned to Oct 2024 notes (upgraded from Baa1 by Jun 2024) [S10] |
Debt Maturity Profile
| Maturity | Coupon | Original principal (USD Mn) |
|---|---|---|
Jul 3, 2027 | 4.950% | 750 |
Mar 15, 2028 | 1.150% | 500 |
Mar 15, 2028 | 4.500% | 1,000 |
Feb 15, 2029 | 4.875% | 750 |
Jun 1, 2029 | 2.000% | 475 |
Jun 15, 2029 | 3.450% | 1,000 |
Feb 15, 2030 | 4.625% | 750 |
Mar 15, 2030 | 4.650% | 700 |
Mar 15, 2031 | 1.500% | 1,000 |
Jul 3, 2031 | 4.950% | 750 |
Mar 15, 2032 | 4.800% | 750 |
Apr 15, 2032 | 4.150% | 1,000 |
Feb 15, 2033 | 4.625% | 500 |
Feb 15, 2034 | 4.875% | 1,250 |
Mar 15, 2035 | 4.950% | 1,500 |
Jul 15, 2039 | 4.000% | 500 |
Jun 1, 2041 | 2.950% | 475 |
Jul 15, 2049 | 4.150% | 1,000 |
Nov 15, 2050 | 2.500% | 500 |
Oct 15, 2054 | 5.350% | 1,250 |
Analyst Conclusions
Management guidance (FY2026, as of Jul 28, 2026) [S2].
-
Revenue: $26.275–26.475B, up about 4.9% at the midpoint versus FY2025.
-
Adjusted operating EBITDA: $8.15–8.25B, a 31.0–31.2% margin.
-
Free cash flow: $3.75–3.85B.
-
Shareholder returns: about $3.5B.
Beyond 2026, management has said it will next comment on 2027 with Q4 FY2026 results. It expects sustainability EBITDA to approach $1B in 2027 [S1]. The 2027 Investor Day targets (revenue $28.5–29.25B) are explicitly not reaffirmed [S1][S17].
Given the guidance, the implied 2026 picture is:
-
Mid-single-digit revenue growth of about 4.9%.
-
EBITDA growth of about 6% on a comparable basis.
-
High-single-digit adjusted EPS growth: H1 FY2026 adjusted EPS was +6.7% [S2][S3].
-
Free cash flow growth of about 29%.
Bull case
-
Free cash flow inflection is structural, not cyclical. Growth capex falls by more than $400M in 2026 [S1]. Combined with OCF growth of about 12% in Q2 FY2026 [S2], this supports free cash flow per share compounding above 15% into 2027. At about a 4.7% 2026E FCF yield, the shares look inexpensive for an A-rated compounder.
-
Self-help margin levers are visible and quantified. These include HCS SG&A convergence (22.8% of revenue versus 9.2% for the Legacy Business), about $300M of synergies, and the sustainability EBITDA ramp from about $300M in 2023 toward about $1B in 2027. EBITDA was held despite the revenue cut in Jul 2026 [S1][S2].
-
The de-rating creates entry. The stock is down about 7% year to date and near its 52-week low, against a mean target of about $260 [S11]. Buybacks of about $2B per year at these prices retire about 2.4% of shares annually.
Bear case
-
Volume is rolling over. C&D volume fell 1.6% in H1 FY2026, and residential and industrial weakness forced a revenue cut [S2]. Price-led growth without volume narrows the margin cushion if cost inflation re-accelerates, for example from fuel.
-
Healthcare Solutions may be a value trap. Revenue is shrinking (-1.0% in H1 FY2026), the business carries large goodwill and intangibles, and it earns half the Legacy margin [S1][S2]. Synergies may not offset attrition, and impairment risk exists.
-
Commodity, policy and leadership overhang. RINs are down about 24% from FY2024 levels. PFAS regulation is a risk. The 2026 run of impairments ($248M in FY2025) shows execution risk, and a new CEO from Jan 2027 adds strategy uncertainty [S1][S6].
Catalysts and monitorables (next 12 months)
| Date / period | Catalyst | What to watch |
|---|---|---|
| Oct 27–28, 2026 | Q3 FY2026 results [S24] | Volume trajectory (ex-wildfire), HCS growth inflection, FY2026 guide reaffirmation, RIN and commodity sensitivity |
| Dec 2026 | Board dividend signal for 2027 | Size of the increase; buyback cadence |
| Jan 4, 2027 | Morris becomes CEO [S6] | Any strategic reset (HCS portfolio, M&A appetite) |
| Late Jan / Feb 2027 | Q4 FY2026 results and FY2027 guidance | Update versus Investor Day 2027 targets; sustainability EBITDA about $1B |
| 2026–2027 | RNG and MRF completions | 6 RNG and 4 recycling projects in 2026 [S1] |
| Ongoing | EPA Renewable Fuel Standard volumes; PFAS rules; EPR rollouts | RIN pricing; compliance costs |
| Ongoing | Credit ratings | Outlook changes after deleveraging |
Analyst verdict
WM enters late 2026 as a fundamentally stronger but more complex company than the one that began the decade. The legacy solid-waste engine remains the best large-cap asset in North American waste. It combines the deepest landfill network, more than 72% internalization, about 6% core price and a 38–39% segment EBITDA margin. Its Collection and Disposal segment alone produces about $8B of EBITDA. The 2022–2025 capital cycle also bought something tangible: a recycling and RNG platform whose earnings have roughly doubled since 2023 and that management expects to approach $1B in 2027.
The near-term debate is no longer about growth investment. It is about harvest quality. 2026 guidance implies about $3.8B of free cash flow, close to 30% growth, with about 90% returned to shareholders. Yet the market has de-rated the shares about 7% year to date for three reasons: softer volumes, a shrinking Healthcare Solutions top line, and leadership turnover. We view that de-rating as partially justified. Stericycle has not yet proven it can grow organically. The 2025 impairments ($248M) also show that not every circularity bet works.
On balance, the risk-reward skews positive. At about 12.7x 2026E EBITDA, about 26x trailing adjusted EPS and a 4.7% free cash flow yield, investors pay a sub-peer multiple for:
-
A defensive (beta 0.43), investment-grade compounder.
-
Visible self-help: HCS SG&A convergence and about $300M of synergies.
-
Shrinking capital intensity.
The transition to John Morris, a 30-year operator who has run WM's field organization, argues for continuity rather than a strategic lurch.
Verdict: Constructive (Outperform bias), with execution-dependent upside. The thesis is validated if Q3 and Q4 FY2026 show stabilizing ex-wildfire volume, HCS returning to positive organic growth, and FY2027 guidance reaffirming a sustainability EBITDA of about $1B alongside free cash flow above $4B. It is invalidated by further revenue guide cuts, new impairments at HCS, or a material RIN or commodity downturn.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / key dates | Prior roles | Education | Age / born |
|---|---|---|---|---|---|
James C. Fish, Jr. | CEO and director | CEO since Nov 2016; President 2016–May 2025; retiring as CEO Jan 4, 2027, then advisor to mid-Feb 2027 [S4][S6] | WM President and CFO; SVP Eastern Group; area and market VP roles; earlier Yellow-Roadway (Westex), TWA, America West, KPMG [S4] | BS accounting, Arizona State; MBA, University of Chicago [S4] | 63 [S4] |
John J. Morris, Jr. | President; CEO-designate (effective Jan 4, 2027) | President since May 2025; also COO May 2025–May 2026 per 8-K; long-time COO before that [S6] | 30+ years of industry experience [S6] | — | 57 [S6] |
David L. Reed | EVP and CFO | CFO since Nov 2025 [S8] | VP and business partner, West Tier; VP and Treasurer; background in investment banking and investor relations [S8] | — | born 1978 [S11] |
Tara J. Hemmer | EVP and COO | COO since May 2026; joined WM 1999 [S7] | SVP and Chief Sustainability Officer; SVP Field Operations; SVP Operations, Safety and Environmental [S7] | — | 53 [S7] |
Charles C. Boettcher | EVP Corporate Development and Chief Legal Officer | — | — | J.D. | born 1974 [S11] |
John A. Carroll | VP and Chief Accounting Officer | — | — | — | born 1973 [S11] |
Johnson Varkey | SVP and Chief Information Officer | — | — | — | born 1973 [S11] |
Kimberly G. Stith | SVP and Chief Human Resources Officer | — | — | — | born 1966 [S11] |
Charles S. Schwager | VP and Chief Compliance and Ethics Officer | — | — | — | — |
Devina A. Rankin | Former EVP and CFO (2017–Nov 2025); executive advisor through Mar 2026 | Retired [S8] | 23 years at WM | — | — |
Rafael E. Carrasco | Former SVP Enterprise Strategy; led HCS integration | Retirement announced May 2026 [S7] | 10 years at WM | — | born 1972 |
Executive Leadership Team by Executive
| Executive | Item | Value (USD) | Source |
|---|---|---|---|
James C. Fish, Jr. (CEO) | Summary Compensation Table total, FY2025 | 19,048,786 | [S4] XBRL pay-versus-performance table |
James C. Fish, Jr. | Compensation actually paid, FY2025 | 27,485,198 | [S4] |
Non-CEO NEOs (Reed, Rankin, Morris, Hemmer, Carrasco) | Average SCT total, FY2025 | 4,897,001 | [S4] |
Non-CEO NEOs | Average compensation actually paid, FY2025 | 6,742,958 | [S4] |
Tara J. Hemmer | New base salary on COO promotion (May 2026) | 850,000 | [S7] |
Board of Directors
| Director | Age | Since | Independent | Committees | Principal occupation |
|---|---|---|---|---|---|
Kathleen M. Mazzarella (Chair) | 66 | Oct 2015; Chair since May 2023 | Yes | Audit, MD&C, Nominating & Governance | Chairman, President and CEO, Graybar Electric; director of Cigna and Core & Main |
James C. Fish, Jr. | 63 | Nov 2016 | No | — | CEO, WM; director of Caterpillar |
Thomas L. Bené | 63 | Mar 2024 | Yes | MD&C | President and CEO, Breakthru Beverage Group; former Sysco CEO |
Bruce E. Chinn | 69 | Feb 2023 | Yes | Audit | Former CEO, Chevron Phillips Chemical; director of Celanese |
Andrés R. Gluski | 68 | Jan 2015 | Yes | Audit; MD&C (Chair) | President and CEO, AES Corp. |
Victoria M. Holt | 68 | Jan 2013 | Yes | Audit; Nominating & Governance (Chair) | Former CEO, Proto Labs; director of Piper Sandler and A.O. Smith |
Sean E. Menke | 57 | Mar 2021 | Yes | Audit; Nominating & Governance | Former CEO and Executive Chair, Sabre; director of JetBlue |
William B. Plummer | 67 | Aug 2019 | Yes | Audit (Chair); MD&C | Former CFO, United Rentals; director of Global Payments |
Maryrose T. Sylvester | 60 | Mar 2021 | Yes | MD&C; Nominating & Governance | Former U.S. MD, ABB Electrification; director of Harley-Davidson, Vontier and Flex |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
May 2025 | Morris named President; Fish keeps the CEO title | Succession grooming [S4] |
Aug 21, 2025 | CFO Rankin to retire; Reed named CFO from Nov 2025 | Internal promotion of a 47-year-old finance and operations hybrid [S8] |
May 13, 2026 | Hemmer named EVP and COO; Carrasco retiring; HCS now reports to Morris | Unifies operations with the sustainability businesses [S7] |
Aug 26, 2026 | Fish to retire Jan 4, 2027; Morris named CEO | Orderly, internal succession; Fish advises until mid-Feb 2027 [S6] |
Major Shareholders
| # | Holder | Shares (M) | % of outstanding (computed) |
|---|---|---|---|
| 1 | Vanguard (Capital Management 25.2M + Portfolio Management 10.1M) | 35.3 | 8.8 |
| 2 | BlackRock, Inc. | 30.7 | 7.6 |
| 3 | Gates Foundation Trust | 26.7 | 6.7 |
| 4 | State Street Corp. | 18.0 | 4.5 |
| 5 | Capital Research Global Investors | 10.4 | 2.6 |
| 6 | Geode Capital Management | 9.1 | 2.3 |
| 7 | Ameriprise Financial | 7.1 | 1.8 |
| 8 | Morgan Stanley | 6.6 | 1.6 |
| 9 | Parnassus Investments | 4.8 | 1.2 |
| 10 | Norges Bank | 4.8 | 1.2 |
Competitive Landscape
Peer Comparison FY2025
| Competitor | Segment overlap | FY2025 revenue | Adjusted EBITDA margin FY2025 | Positioning versus WM |
|---|---|---|---|---|
Republic Services (RSG) | C&D, recycling, RNG (JVs), environmental solutions | About $16.6B (+3.5%) | 32.0% | #2 U.S. integrated player; strong pricing; polymer centers |
Waste Connections (WCN) | C&D in secondary and rural markets; Canada; E&P waste | $9.467B | 33.0% | Highest margins; franchise and secondary-market focus |
GFL Environmental (GFL) | C&D in Canada and U.S. | C$6.616B | 30.0% | Fast-growing roll-up; divested Environmental Services in 2025 |
Casella Waste Systems (CWST) | C&D and recycling in the Northeast and Mid-Atlantic | $1.837B (+18%) | NA (EBITDA +17%) | Regional consolidator |
Clean Harbors (CLH) | Hazardous and industrial waste; overlaps WM hazardous landfills and HCS | — | — | Hazardous-waste leader |
Rumpke Waste & Recycling | C&D in Ohio and Kentucky | Not publicly disclosed (private) | — | Regional private |
WIN Waste Innovations | C&D, waste-to-energy (Northeast) | Not publicly disclosed (private) | — | Private-equity owned |
Waste Pro USA | C&D (Southeast) | Not publicly disclosed (private) | — | Private |
Recology | C&D (West Coast; employee-owned) | Not publicly disclosed (private) | — | Municipal franchises |
Sharps Compliance, Daniels Health and regional medical-waste haulers | HCS (regulated medical waste) | Not publicly disclosed (private) | — | Niche challengers to former Stericycle share |
Iron Mountain (shredding) and regional shredders | HCS SID | NA (segment) | — | SID competitors |
Independent RNG developers (e.g., OPAL Fuels, Montauk; bp's Archaea) | Renewable Energy | — | — | Compete for landfill-gas rights and RNG offtake |
Peer Comparison FY2025 — Revenue
| Metric | WM | Republic Services | Waste Connections | GFL (CAD) |
|---|---|---|---|---|
Revenue (local M) | 25,204 | 16,590 | 9,467 | 6,616 |
Revenue growth (%) | 14.2 | 3.5 | 6.1 | 7.8 |
Adjusted EBITDA (local M) | 7,582 | 5,310 | 3,125 | 1,985 |
Adjusted EBITDA margin (%) | 30.1 | 32.0 | 33.0 | 30.0 |
Net income (local M) | 2,708 | 2,140 | 1,077 | 241 |
Net margin (%) | 10.7 | 12.9 | 11.4 | 3.6 |
2026 guided revenue (local M, midpoint) | 26,375 | 17,100 | 9,925 | 7,000 |
2026 guided adjusted EBITDA (local M, midpoint) | 8,200 | 5,500 | 3,313 | 2,140 |
Recent Developments
--



